Skip to main content

Novel Approach to Chlamydia trachomatis Infections in Female and Male

  • Chapter
  • First Online:
Sexually Transmitted Infections

Abstract

Chlamydia is a very common, curable sexually transmitted infection (STI) caused by the Chlamydia trachomatis bacteria. Chlamydia prevalence is higher in young women and is similar in some developed countries. Generally the infections are asymptomatic, resulting in a large reservoir of undetected, untreated infections. Untreated chlamydia infection may result in long-term sequelae in women including pelvic inflammatory disease (PID) and ectopic pregnancy. Detection of chlamydia has become easier with the recent introduction of rapid, sensitive, affordable, and non-invasive DNA tests. Treatment is also straightforward and inexpensive with doxycycline or azithromycin. Chlamydia screening therefore has been or is being implemented in various developed countries. However much of the epidemiology of chlamydia remains poorly understood and there are many questions regarding the long-term impact of interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. World Health Organization. Global incidence and prevalence of selected curable sexually transmitted infections-2008. Geneva: WHO; 2012. p. 1–28.

    Google Scholar 

  2. Newman L, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS ONE. 2015;10(12):e0143304.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Workowski KA, Bolan GA, CDC (Centers for Disease Control, Prevention). Sexually transmitted diseases treatment guidelines, 2015. Morb Mortal Wkly Rep. 2015;64(RR3):1–137.

    Google Scholar 

  4. Lanjouw E, Ouburg S, de Vries HJ, Stary A, Radcliffe K, Unemo M. 2015 European guideline on the management of Chlamydia trachomatis infections. Int J STD AIDS. 2016;27(5):333–48.

    Article  PubMed  Google Scholar 

  5. Redmond SM, et al. Genital chlamydia prevalence in Europe and non-European high income countries: systematic review and meta-analysis. PLoS One. 2015;10(1):e0115753.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Crichton J, Hickman M, Campbell R, Batista-Ferrer H, Macleod J. Socioeconomic factors and other sources of variation in the prevalence of genital chlamydia infections: a systematic review and meta-analysis. BMC Public Health. 2015;15(1):729.

    Article  PubMed  PubMed Central  Google Scholar 

  7. CDC. Sexually transmitted disease surveillance 2016. U.S Dep. Heal. Hum. Serv. 2017.

    Google Scholar 

  8. Schillinger JA, et al. Genotype-specific concordance of chlamydia trachomatis genital infection within heterosexual partnerships. Sex Transm Dis. 2016;43(12):741–9.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Quinn TC, et al. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA. 1996;276(21):1737–42.

    Article  PubMed  Google Scholar 

  10. Bellaminutti S, Seraceni S, de Seta F, Gheit T, Tommasino M, Comar M. HPV and Chlamydia trachomatis co-detection in young asymptomatic women from high incidence area for cervical cancer. J Med Virol. 2014;86(11):1920–5.

    Article  PubMed  Google Scholar 

  11. Landers DV, Sweet RL. Tubo-ovarian abscess: contemporary approach to management. Rev Infect Dis. 1983;5(5):876–84.

    Article  PubMed  Google Scholar 

  12. Detels R, Green AM, Klausner JD, Katzenstein D, Gaydos C, Handsfield H, Pequegnat W, Mayer K, Hartwell TD, Quinn TC. The incidence and correlates of symptomatic and asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae infections in selected populations in five countries. Sex Transm Dis. 2011;38(6):503–9.

    PubMed  PubMed Central  Google Scholar 

  13. Kent CK, Chaw JK, Wong W, Liska S, Gibson S, Hubbard G, Klausner JD. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis. 2005;41(1):67.

    Article  PubMed  Google Scholar 

  14. Cecil JA, Howell MR, Tawes JJ, Gaydos JC, McKee KT Jr, Quinn TC, Gaydos CA. Features of Chlamydia trachomatis and Neisseria gonorrhoeae infection in male Army recruits. J Infect Dis. 2001;184(9):1216–9.

    Article  PubMed  Google Scholar 

  15. Martin-Iguacel R, Llibre JM, Nielsen H, Heras E, Matas L, Lugo R, Clotet B, Sirera G. Lymphogranuloma venereum proctocolitis: a silent endemic disease in men who have sex with men in industrialised countries. Eur J Clin Microbiol Infect Dis. 2010;29(8):917–25.

    Article  PubMed  Google Scholar 

  16. Karim S, Souho T, Benlemlih M, Bennani B. Cervical cancer induction enhancement potential of Chlamydia trachomatis: a systematic review. Curr Microbiol. 2018;75(12):1667–74.

    Article  PubMed  Google Scholar 

  17. Gottlieb SL, Xu F, Brunham RC. Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: interpretation of findings from randomized controlled trials. Sex Transm Dis. 2013;40(2):97–102.

    Article  PubMed  Google Scholar 

  18. Low N, et al. Screening for genital chlamydia infection. Cochrane Database Syst Rev. 2016;2016(9):CD010866.

    PubMed Central  Google Scholar 

  19. Wiesenfeld HC. Screening for Chlamydia trachomatis infections in women. N Engl J Med. 2017;376(8):765–73.

    Article  PubMed  Google Scholar 

  20. Centers for Disease Control and Prevention. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014. MMWR Recomm Rep. 2014;63(2):1–19.

    Google Scholar 

  21. Dombrowski JC. Do women need screening for extragenital gonococcal and chlamydial infections? Sex Transm Dis. 2015;42(5):240–2.

    Article  PubMed  Google Scholar 

  22. Coll J, et al. Early detection of HIV infection and of asymptomatic sexually transmitted infections among men who have sex with men. Clin Microbiol Infect. 2018;24(5):540–5.

    Article  PubMed  Google Scholar 

  23. Ong JJ, et al. Should asymptomatic men who have sex with men be screened for oropharyngeal Chlamydia? Clinical outcomes from a cross-sectional study. Sex Transm Dis. 2018;45(2):103–6.

    Article  PubMed  Google Scholar 

  24. Reyburn H. WHO guidelines for the treatment of Chlamydia trachomatis. Geneva: WHO; 2016.

    Google Scholar 

  25. Luisa F-B, et al. Home-based versus clinic-based specimen collection in the management of Chlamydia trachomatis and Neisseria gonorrhoeae infections SO. Cochrane Database Syst Rev. 2015;9:CD011317.

    Google Scholar 

  26. Levi AW, Beckman D, Hui P, Schofield K, Harigopal M, Chhieng DC. Comparing two methods of detection for Chlamydia trachomatis in liquid-based papanicolaou tests. Am J Clin Pathol. 2012;138(2):236–40.

    Article  PubMed  Google Scholar 

  27. Kelly H, et al. Systematic reviews of point-of-care tests for the diagnosis of urogenital Chlamydia trachomatis infections. Sex Transm Infect. 2017;93(S4):S22–30.

    Article  PubMed  Google Scholar 

  28. Committee on Obstetric Practice. Committee opinion. Am J Obstet Gynecol. 2015;654:1–4.

    Google Scholar 

  29. van Aar F, van Benthem BHB, van den Broek IVF, Götz HM. STIs in sex partners notified for chlamydia exposure: implications for expedited partner therapy. Sex Transm Infect. 2018;94(8):619–21.

    Article  PubMed  Google Scholar 

  30. van der Helm JJ, Koekenbier RH, van Rooijen MS, Schim van der Loeff MF, de Vries HJC. What is the optimal time to retest patients with a urogenital Chlamydia infection? A randomized controlled trial. Sex Transm Dis. 2018;45(2):132–7.

    Article  PubMed  Google Scholar 

  31. Geisler WM, et al. Azithromycin versus doxycycline for urogenital Chlamydia trachomatis infection. N Engl J Med. 2015;373(26):2512–21.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Kissinger PJ, et al. Azithromycin treatment failure for chlamydia trachomatis among heterosexual men with nongonococcal urethritis. Sex Transm Dis. 2016;43(10):599–602.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Kong FYS, et al. Azithromycin versus doxycycline for the treatment of genital chlamydia infection: A meta-analysis of randomized controlled trials. Clin Infect Dis. 2014;59(2):193–205.

    Article  PubMed  Google Scholar 

  34. Williams JA, Ofner S, Batteiger BE, Fortenberry JD, Van Der Pol B. Duration of polymerase chain reaction-detectable DNA after treatment of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis infections in women. Sex Transm Dis. 2014;41(3):215–9.

    Article  PubMed  Google Scholar 

  35. Gannon-Loew KE, Holland-Hall C, Bonny AE. A review of expedited partner therapy for the management of sexually transmitted infections in adolescents. J Pediatr Adolesc Gynecol. 2017;30(3):341–8.

    Article  PubMed  Google Scholar 

  36. Barbee LA, Khosropour CM, Dombrowski JC, Manhart LE, Golden MR. An estimate of the proportion of symptomatic gonococcal, chlamydial and non-gonococcal nonchlamydial urethritis attributable to oral sex among men who have sex with men: a case-control study. Sex Transm Infect. 2016;92(2):155–60.

    Article  PubMed  Google Scholar 

  37. Marcus JL, Kohn RP, Barry PM, Philip SS, Bernstein KT. Chlamydia trachomatis and Neisseria gonorrhoeae transmission from the female oropharynx to the male urethra. Sex Transm Dis. 2011;38(5):372–3.

    Article  PubMed  Google Scholar 

  38. Kintner J, Lajoie D, Hall J, Whittimore J, Schoborg RV. Commonly prescribed beta-lactam antibiotics induce C. trachomatis persistence/stress in culture at physiologically relevant concentrations. Front Cell Infect Microbiol. 2014;4(April):1–10.

    Google Scholar 

  39. Ross J, Guaschino S, Cusini M, Jensen J. 2017 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS. 2018;29(2):108–14.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

De Seta, F., Comar, M., De Santo, D., Larsen, B., Zito, G. (2020). Novel Approach to Chlamydia trachomatis Infections in Female and Male. In: Cristaudo, A., Giuliani, M. (eds) Sexually Transmitted Infections . Springer, Cham. https://doi.org/10.1007/978-3-030-02200-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-02200-6_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-02199-3

  • Online ISBN: 978-3-030-02200-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics